On October 11, 2023, the U.S. Food and Drug Administration (FDA) approved a combination of Braftovi (encorafenib) and Mektovi (binimetinib) for people with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. BRAF is a less common [...]
Question: I have many questions about my lung cancer diagnosis and treatment options, but I’m worried about bothering my doctor. What should I do? Answer:* If you have an oncologist who makes you feel like you shouldn’t be contacting them, [...]
After spending over 20 years in the hospitality field, Bob Iles changed careers and joined the stock brokerage industry before retiring almost six years ago. He and his husband live in Palm Springs, CA, where he enjoys swimming in [...]
Question: What is the difference between neo-adjuvant therapy and adjuvant therapy? Answer: “Neo-adjuvant” and “adjuvant” are terms used in the context of cancer treatment to refer to therapies that are given before or after the primary treatment, such as surgery [...]
Every year, lung cancer professionals from across the globe gather to connect and learn at the World Conference for Lung Cancer (WCLC). Members of the GO2 team just returned from WCLC 2023 hosted in Singapore, where they presented GO2’s [...]
By Mike Knecht Mike Knecht retired from his career as an electrical contractor and business owner in 2019 and spent the following year traveling through the United States and Africa. In early 2023, he and his wife, Lois, sold their home in Maryland to live full-time in their vacation/retirement home in West [...]
Small cell lung cancer (SCLC), which represents about 15% of all lung cancer diagnoses, is an often-aggressive form of lung cancer that has historically been difficult to treat. However, the science driving new treatments for SCLC is moving faster than [...]
Question: A small 2 cm nodule was recently found in my lung and I had an upper lobectomy. The surgeon said the margins were clear and there was no cancer found in the lymph nodes. They said the stage [...]
Joelle Fathi is on a mission to make a meaningful contribution and transform healthcare to make it more equitable. It’s an ambitious goal that GO2 for Lung Cancer’s chief healthcare delivery officer believes is essential to increase lung cancer [...]
The American Society of Clinical Oncology (ASCO) hosts an annual meeting every spring where oncologists and other physicians, researchers, industry members, and advocacy organizations like GO2 come together to share and learn the latest and most exciting news on [...]